News
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
20 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
20 Mar 24
Movers
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
19 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
19 Mar 24
Movers
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
19 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Nasdaq Down 100 Points; US Housing Starts Surge In February
19 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why
19 Mar 24
Biotech, News, Health Care, Movers, General
Seelos Therapeutics Provides Update On Top-Line Results From Its Amyotrophic Lateral Sclerosis Study With SLS-005
19 Mar 24
Biotech, News, FDA, General
Reported Earlier, 'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
14 Mar 24
Biotech, News, Legal, General
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
15 Feb 24
Cannabis, Psychedelics, Financing, Legal, Management, Global
'FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says' - Marijuana Moment
12 Feb 24
Biotech, News, FDA, General
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
27 Jan 24
Cannabis, Psychedelics, Financing, Legal, Management, Global, Top Stories, Markets
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
26 Jan 24
Biotech, Cannabis, Psychedelics, Regulations, Health Care, Financing, Offerings, Legal, Management, Global
Seelos Therapeutics Announces Receipt Of Minutes From Its End Of Phase II Meeting With The U.S. FDA Highlighting Modifications To The Primary And Secondary Endpoints Of Its Phase II Study Of SLS-002
22 Jan 24
Biotech, News, FDA, General
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
12 Jan 24
Cannabis, News, Penny Stocks, Psychedelics, Markets, Interview
12 Health Care Stocks Moving In Friday's Intraday Session
12 Jan 24
Movers
Seelos Therapeutics Filed U.S. Patent Application #20240009113 : Treatment Of Protein Aggregation Myopathic And Neurodegenerative Diseases By Parenteral Administration Of Trehalose
11 Jan 24
News
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
8 Jan 24
Biotech, Cannabis, News, Penny Stocks, Psychedelics, Markets
'New Bipartisan Washington Bill Would Legalize Psilocybin Therapy For Veterans And First Responders' - Marijuana Moment
8 Jan 24
Macro Economic Events, News, Legal, Economics
Press releases
Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)
19 Mar 24
Press Releases
Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
26 Jan 24
Offerings, Press Releases
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
24 Jan 24
Small Cap, Opinion, Press Releases
Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002
22 Jan 24
Press Releases
Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024
2 Jan 24
Press Releases